Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

Question 2

How does switching to denosumab compare to continuing with alendronate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of with denosumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will be done to assess my bone health during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Transitioning From Alendronate to Denosumab clinical trial (NCT00377819). Contact the study team or your healthcare provider for specific answers.

What this study is about